ACP and AAFP release new hypertension recommendations

January 16, 2017

1. ACP and AAFP release guideline for treatment of hypertension in adults 60 years old and older
For otherwise healthy adults, a less aggressive treatment target is recommended

The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) have published an evidence-based clinical practice guideline on the appropriate systolic blood pressure (the top number in a reading) target for adults 60 years old and older with hypertension. The physicians' groups say that a less aggressive target provides a good balance of benefits and harms for older adults who are otherwise healthy. The joint guideline is published in Annals of Internal Medicine and a summary of the guideline will be published in Annals of Family Medicine.

ACP and AAFP recommend that physicians initiate treatment in adults aged 60 years old and older with persistent systolic blood pressure at or above 150 millimeters of mercury (mmHg) to reduce the risk of mortality, stroke, and cardiac events. The evidence suggests that any additional benefit from aggressive blood pressure control is small, with a lower magnitude of benefit and inconsistent results across outcomes. Some patients may have falsely elevated readings in clinical settings, which is known as "white coat hypertension," therefore, it is important for physicians to ensure that they are accurately measuring blood pressure before initiating or changing treatment. The most accurate measurements come from multiple blood pressure measurements made over time in clinical settings or at home.

The guidelines recommend that physicians consider initiating or intensifying drug therapy in adults aged 60 years old and older with a history of stroke or transient ischemic attack to achieve a target systolic blood pressure of less than 140 mm Hg to reduce the risk of recurrent stroke. Physicians should also consider initiating or intensifying pharmacological treatment in some adults aged 60 years old and older at high cardiovascular risk, based on individualized assessment, to achieve a target systolic blood pressure of less than 140 mm Hg to reduce the risk of stroke or cardiac events.

Hypertension, an elevation of systemic arterial blood pressure, is one of the most common chronic diseases in the United States. About 65 percent of adults in the U.S. over the age of 60 have hypertension, and the disease affects about 29 percent of all adults in the nation. ACP and AAFP are two of the largest physician organizations in the U.S. representing primary care doctors. Their combined 420,900 members, including internal medicine physicians (internists) and family physicians, treat the majority of patients in the U.S. with hypertension.

Note: For an embargoed PDF, please contact Cara Graeff. To speak with someone from ACP, please contact Steve Majewski at SMajewski@acponline.org or 215-351-2514. To speak with someone from the AAFP, please contact Stephanie Wilken at SWilken@aafp.org or 800-274-2237 , ext. 5221.

2. Patient and provider interventions no better than usual care for osteoarthritis

Findings contradict previous study showing modest improvements from combined interventions

Abstract: http://annals.org/aim/article/doi/10.7326/M16-1245 URLs go live when the embargo lifts

No intervention, whether patient-based, provider-based, or a combination of the two, provided improvements over usual care for patients with knee osteoarthritis. These findings contradict conclusions from an earlier study suggesting that a combined intervention provided modest improvements in function and activity compared with usual care. The results of a cluster randomized trial are published in Annals of Internal Medicine.

Managing pain and function associated with hip or knee osteoarthritis requires both medical and behavioral strategies, but recommended therapies are underused. A single-site study conducted in a Department of Veterans Affairs medical center showed that a combined patient and provider intervention improved outcomes for patients with knee osteoarthritis, but it did not assess separate effects of the interventions.

To examine whether patient-based, provider-based, and patient-provider interventions improve osteoarthritis outcomes, researchers randomly assigned 537 outpatients with symptomatic hip or knee osteoarthritis at 10 Duke University Health System community-based primary care clinics to receive care using one of the three interventions. The telephone-based patient intervention focused on weight management, physical activity, and cognitive behavioral pain management. The provider intervention involved delivery of patient-specific osteoarthritis treatment recommendations to primary care providers through electronic medical records. The patient-provider intervention combined both approaches.

At 12 months, none of the osteoarthritis intervention groups showed greater improvements in outcomes compared with usual care. The authors note that the intervention was low-intensity. The authors suggest that higher-intensity interventions are needed to make more meaningful improvements in outcomes.

Note: For an embargoed PDF, please contact Cara Graeff. For an interview with the lead author, Dr. Kelli Allen, please contact Bradd Pavur at Bradd_Pavur@med.unc.edu or 919-843-7868.
-end-
Also new in this issue:

Historical Perspective on the Rise and Fall and Rise of Antibiotics and Human Weight Gain

Scott H. Podolsky, MD
History of Medicine
Abstract: http://annals.org/aim/article/doi/10.7326/M16-1855
URL goes live when the embargo lifts

American College of Physicians

Related Hypertension Articles from Brightsurf:

Risk of target organ damage in patients with masked hypertension versus sustained hypertension
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.1261, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Overactive enzyme causes hereditary hypertension
After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure.

Diagnosing hypertension in children
Study results call into question the utility of testing blood pressure load--the proportion of elevated blood pressure readings detected over 24 hours--for diagnosing hypertension in children.

When the best treatment for hypertension is to wait
A new study concluded that a physician's decision not to intensify hypertension treatment is often a contextually appropriate choice.

Treatment of hypertension induced albuminuria
Patients with albuminuria will usually need more than one drug to achieve blood pressure control, particularly if the aim is also to reduce albuminuria.

Diagnosing and treating resistant hypertension
Resistant blood pressure affects 12 percent to 15 percent of people currently being treated for high blood pressure.

Dementia can be caused by hypertension
A new study in Cardiovascular Research indicates that patients with high blood pressure are at a higher risk of developing dementia.

Hormone imbalance causes treatment-resistant hypertension
British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

Breastfeeding reduces hypertension risk
A study published in the American Journal of Hypertension indicates that women who breastfeed more children, and for longer periods of time, are less likely to suffer from hypertension after they reach menopause.

Lung cancer triggers pulmonary hypertension
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension.

Read More: Hypertension News and Hypertension Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.